Fexofenadine/phenylephrineAlternative Names: FEX60/PE10; Phenylephrine/fexofenadine
Latest Information Update: 09 Dec 2015
At a glance
- Originator Sanofi
- Class Acetic acids; Antiallergics; Benzhydryl compounds; Decongestants; Ethanolamines; Nonsedating antihistamines; Piperidines; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Histamine H1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Allergic rhinitis
Most Recent Events
- 01 Mar 2015 Phase-III clinical trials in Allergic rhinitis in Japan (PO) (NCT02401191)